Accord-UK launches Pelgraz injector and app
The product is designed to help reduce hospital trips for cancer patients
Read Moreby Selina McKee | Oct 1, 2020 | News | 0
The product is designed to help reduce hospital trips for cancer patients
Read Moreby Anna Smith | Mar 4, 2019 | News | 0
Napp Pharmaceuticals has launched Pelmeg – a pegfilgrastim biosimilar – across the UK.
Read Moreby Anna Smith | Feb 7, 2019 | News | 0
Mundipharma has announced the launch of Pelmeg (pegfilgrastim), a biosimilar of Neulasta, following its European Commission (EC) approval in November 2018.
Read Moreby Selina McKee | Nov 27, 2018 | News | 0
The Mundipharma network of independent associated companies says European regulators have approved use of Pelmeg, a biosimilar of Amgen’s white blood cell booster Neulasta.
Read Moreby Selina McKee | Jun 5, 2018 | News | 0
Mylan and Biocon’s Fulphila has become the first biosimilar of Amgen’s Neulasta to be approved by the US Food and Drug Administration.
Read Moreby Selina McKee | Mar 7, 2018 | News | 0
European regulators have accepted a resubmission of Gedeon Richter’s biosimilar to Amgen’s Neulasta.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
